Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Trichoscopy is a non-invasive way to diagnose hair and scalp problems without needing hair samples.

Hair dye can cause serious scalp issues, including skull erosion.

HASHA is a safe and effective option for chin augmentation.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Androgens increase growth factors in skin cells, which may lead to acne.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

"Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.

The document is a detailed medical reference on skin and genetic disorders.

Minoxidil is effective for hair growth and safe for long-term use.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Topical minoxidil may slow hair loss but often doesn't lead to satisfactory hair regrowth and requires ongoing treatment.

The human hair follicle can store topical compounds and be targeted for drug delivery with minimal side effects.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

The document concludes that scalp conditions have various causes and can present in many different ways.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Topical minoxidil might potentially cause vision problems, but more research is needed.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Bimatoprost is slightly more effective than minoxidil for eyebrow growth, and both are safe.